PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.\', \'Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. allanxin@hotmail.com.\', \'Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. xieqingrjh@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11684-021-0847-4
?:doi
?:hasPublicationType
?:journal
  • Frontiers of medicine
is ?:pmid of
?:pmid
?:pmid
  • 33909259
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.913
?:rankingScore_hIndex
  • 25
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33909259>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33909259>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all